Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Part of paid clinical trials in Nashville, Tennessee.
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Study ID
- NCT00899301
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- biologic sample preservation procedure — OTHERTissue, urine and blood collection.
Study Details
RATIONALE: Collecting and storing samples of tissue, blood, and urine from patients with or without breast cancer to study in the laboratory may help the study of cancer. PURPOSE: This research study is collecting and storing tissue samples from women with or without breast cancer.
Key Dates
- Start date
- Jan 22, 2004
- Status verified
- Aug 2024
- Primary completion
- Mar 31, 2027
- Completion
- Mar 31, 2027
Study Design
- Enrollment
- 4,000 participants (estimated)
Arms
- Arm: Patients with Breast Cancer
- Arm: Patients without breast cancer
Primary Outcome Measure
Creation of a tissue repository that contains DNA, RNA, or protein from tumor tissue or normal tissue, peripheral blood lymphocytes, and plasma that are linked to frozen and/or paraffin-embedded pathology specimens [ Time Frame: 5 years ]
Central Contacts
- VICC Clinical Trials Information Program800-811-8480
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Vanderbilt-Ingram Cancer Center | Nashville | Tennessee | 37232-6838 | Clinical Trials Office - Vanderbilt-Ingram Cancer Center 800-811-8480 |
Find similar trials in Nashville, TN
By condition
By specialty
By research site
Related Studies
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression ProfilesRecruiting · Agendia · Birmingham, Alabama
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast CancerPHASE3 · Recruiting · Canadian Cancer Trials Group · Fairbanks, Alaska